| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| b' Hana P\\xc5\\x99ikrylov\\xc3\\xa1 Vranov\\xc3\\xa1, Eva H\\xc3\\xa9nykov\\xc3\\xa1, Michaela Kaiserov\\xc3\\xa1, Kate\\xc5\\x99ina Men\\xc5\\xa1\\xc3\\xadkov\\xc3\\xa1, Miroslav Va\\xc5\\xa1t\\xc3\\xadk, Jan Mare\\xc5\\xa1, Petr Hlu\\xc5\\xa1t\\xc3\\xadk, Jana Zapletalov\\xc3\\xa1, Miroslav Strnad, David Stejskal, Petr Ka\\xc5\\x88ovsk\\xc3\\xb. Tau protein, beta-amyloid\\xe2\\x82\\x81\\xe2\\x82\\x8b\\xe2\\x82\\x84\\xe2\\x82\\x82 and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia. Journal of the neurological sciences. vol 343. issue 1-2. 2015-03-09. PMID:24928081.' |
pdd and dlb are sometimes considered a transition between pd and alzheimer dementia (ad). |
2015-03-09 |
2023-08-13 |
Not clear |
| Patrick Aldrin-Kirk, Marcus Davidsson, Staffan Holmqvist, Jia-Yi Li, Tomas Björklun. Novel AAV-based rat model of forebrain synucleinopathy shows extensive pathologies and progressive loss of cholinergic interneurons. PloS one. vol 9. issue 7. 2015-02-27. PMID:24999658. |
while the vulnerability of dopamine cells in the substantia nigra to α-synuclein over-expression, and its link to parkinson's disease, is well studied, animal models recapitulating the cortical degeneration in dementia with lewy-bodies (dlb) are much less mature. |
2015-02-27 |
2023-08-13 |
human |
| Camille Heitz, Vincent Noblet, Benjamin Cretin, Nathalie Philippi, Laurent Kremer, Mélanie Stackfleth, Fabrice Hubele, Jean Paul Armspach, Izzie Namer, Frédéric Blan. Neural correlates of visual hallucinations in dementia with Lewy bodies. Alzheimer's research & therapy. vol 7. issue 1. 2015-02-26. PMID:25717349. |
the aim of this study was to investigate the association between visual hallucinations in dementia with lewy bodies (dlb) and brain perfusion using single-photon emission computed tomography. |
2015-02-26 |
2023-08-13 |
Not clear |
| Yannick Vermeiren, Debby Van Dam, Tony Aerts, Sebastiaan Engelborghs, Jean-Jacques Martin, Peter P De Dey. The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer's disease. Alzheimer's research & therapy. vol 7. issue 1. 2015-02-26. PMID:25717350. |
depression and psychosis are two of the most severe neuropsychiatric symptoms (nps) in dementia with lewy bodies (dlb) and alzheimer's disease (ad). |
2015-02-26 |
2023-08-13 |
Not clear |
| Manabu Ikeda, Etsuro Mori, Kazutaka Matsuo, Masaki Nakagawa, Kenji Kosak. Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial. Alzheimer's research & therapy. vol 7. issue 1. 2015-02-25. PMID:25713599. |
the efficacy of a cholinesterase inhibitor, donepezil, in patients with dementia with lewy bodies (dlb) was investigated to confirm the superiority over placebo in the 12-week, double-blind phase of this phase iii study. |
2015-02-25 |
2023-08-13 |
Not clear |
| Etsuro Mori, Manabu Ikeda, Reiko Nagai, Kazutaka Matsuo, Masaki Nakagawa, Kenji Kosak. Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial. Alzheimer's research & therapy. vol 7. issue 1. 2015-02-25. PMID:25713600. |
the long-term efficacy and safety of donepezil 10 mg in patients with dementia with lewy bodies (dlb) were investigated in a 52-week phase 3 trial. |
2015-02-25 |
2023-08-13 |
Not clear |
| Joanna Narkiewicz, Gabriele Giachin, Giuseppe Legnam. In vitro aggregation assays for the characterization of α-synuclein prion-like properties. Prion. vol 8. issue 1. 2015-02-21. PMID:24552879. |
aggregation of α-synuclein plays a crucial role in the pathogenesis of synucleinopathies, a group of neurodegenerative diseases including parkinson disease (pd), dementia with lewy bodies (dlb), diffuse lewy body disease (dlbd) and multiple system atrophy (msa). |
2015-02-21 |
2023-08-12 |
Not clear |
| Mary Catherine Mayo, Yvette Bordelo. Dementia with Lewy bodies. Seminars in neurology. vol 34. issue 2. 2015-02-21. PMID:24963677. |
dementia with lewy bodies (dlb) is the second most common diagnosis of dementia after alzheimer disease (ad). |
2015-02-21 |
2023-08-13 |
Not clear |
| Stephen N Gompert. Imaging the role of amyloid in PD dementia and dementia with Lewy bodies. Current neurology and neuroscience reports. vol 14. issue 8. 2015-02-21. PMID:25011528. |
cognitive impairment and dementia are significant sequelae of parkinson disease (pd) and comprise a key feature of dementia with lewy bodies (dlb), a disease with similar clinical and neuropathological features. |
2015-02-21 |
2023-08-13 |
human |
| Stephen N Gompert. Imaging the role of amyloid in PD dementia and dementia with Lewy bodies. Current neurology and neuroscience reports. vol 14. issue 8. 2015-02-21. PMID:25011528. |
multiple independent causes have been implicated in pd dementia (pdd) and dlb, among them the accumulation of β-amyloid, a neuropathological hallmark of alzheimer disease. |
2015-02-21 |
2023-08-13 |
human |
| Rachel L Gore, Emma R L C Vardy, John T O'Brie. Delirium and dementia with Lewy bodies: distinct diagnoses or part of the same spectrum? Journal of neurology, neurosurgery, and psychiatry. vol 86. issue 1. 2015-02-20. PMID:24860139. |
dementia with lewy bodies (dlb) is recognised as the second most common form of dementia in older people. |
2015-02-20 |
2023-08-13 |
Not clear |
| Julie Vallortigara, Sindhoo Rangarajan, David Whitfield, Amani Alghamdi, David Howlett, Tibor Hortobágyi, Mary Johnson, Johannes Attems, Clive Ballard, Alan Thomas, John O'Brien, Dag Aarsland, Paul Franci. Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia. F1000Research. vol 3. 2015-02-11. PMID:25671083. |
dementia with lewy bodies (dlb) and parkinson's disease dementia (pdd) together, represent the second most common cause of dementia, after alzheimer's disease (ad). |
2015-02-11 |
2023-08-13 |
Not clear |
| Julie Vallortigara, Sindhoo Rangarajan, David Whitfield, Amani Alghamdi, David Howlett, Tibor Hortobágyi, Mary Johnson, Johannes Attems, Clive Ballard, Alan Thomas, John O'Brien, Dag Aarsland, Paul Franci. Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia. F1000Research. vol 3. 2015-02-11. PMID:25671083. |
interestingly, the correlation between the rate of cognitive decline and the level of dynamin1 remained when the analysis was restricted to the pdd and dlb cases, highlighting an association of dynamin1 with cognitive decline in people with lewy body dementia. |
2015-02-11 |
2023-08-13 |
Not clear |
| Megan K Herbert, Marjolein B Aerts, H Bea Kuiperij, Jurgen A H R Claassen, Petra E Spies, Rianne A J Esselink, Bastiaan R Bloem, Marcel M Verbee. Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias. Alzheimer's & dementia : the journal of the Alzheimer's Association. vol 10. issue 4. 2015-02-09. PMID:24239248. |
overlapping clinical features make it difficult to distinguish dementia with lewy bodies (dlb) from alzheimer's disease (ad) and other dementia types. |
2015-02-09 |
2023-08-12 |
Not clear |
| Megan K Herbert, Marjolein B Aerts, H Bea Kuiperij, Jurgen A H R Claassen, Petra E Spies, Rianne A J Esselink, Bastiaan R Bloem, Marcel M Verbee. Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias. Alzheimer's & dementia : the journal of the Alzheimer's Association. vol 10. issue 4. 2015-02-09. PMID:24239248. |
in this study we aimed to determine whether the combination of cerebrospinal fluid (csf) biomarkers, amyloid-β42 (aβ42), total tau protein (t-tau), and phosphorylated tau protein (p-tau), in combination with 3-methoxy-4-hydroxyphenylethyleneglycol (mhpg), could be useful in discriminating dlb from vascular dementia (vad) and frontotemporal dementia (ftd), as we previously demonstrated for differentiation of dlb from ad. |
2015-02-09 |
2023-08-12 |
Not clear |
| Sandi Culo, Benoit H Mulsant, Jules Rosen, Sati Mazumdar, Richard E Blakesley, Patricia R Houck, Bruce G Polloc. Treating neuropsychiatric symptoms in dementia with Lewy bodies: a randomized controlled-trial. Alzheimer disease and associated disorders. vol 24. issue 4. 2015-02-06. PMID:20625270. |
sensitivity to psychotropic medications presents a therapeutic challenge when treating neuropsychiatric symptoms in patients with dementia with lewy bodies (dlb). |
2015-02-06 |
2023-08-12 |
human |
| Byron Creese, Clive Ballard, Dag Aarsland, Elisabet Londos, Sally Sharp, Emma Jone. Determining the association of the 5HTTLPR polymorphism with delusions and hallucinations in Lewy body dementias. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. vol 22. issue 6. 2015-02-06. PMID:23582751. |
to determine whether the 5httlpr serotonin transporter polymorphism is associated with delusions and hallucinations in people with dementia with lewy bodies (dlb) and parkinson disease dementia (pdd). |
2015-02-06 |
2023-08-12 |
Not clear |
| Yasuhiro Kawamoto, Hidefumi Ito, Takashi Ayaki, Ryosuke Takahash. Immunohistochemical localization of apoptosome-related proteins in Lewy bodies in Parkinson's disease and dementia with Lewy bodies. Brain research. vol 1571. 2015-02-02. PMID:24835407. |
to investigate the role of the apoptosome in patients with parkinson׳s disease (pd), we performed immunohistochemical studies on apoptosome-related proteins in formalin-fixed, paraffin-embedded sections from 8 normal subjects, 10 patients with pd and 5 patients with dementia with lewy bodies (dlb). |
2015-02-02 |
2023-08-13 |
human |
| Guro Berge, Sigrid B Sando, Arvid Rongve, Dag Aarsland, Linda R Whit. Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort. Journal of neurology, neurosurgery, and psychiatry. vol 85. issue 11. 2015-01-26. PMID:24639435. |
results conflict concerning the relevance of apoe alleles on the development of dementia with lewy bodies (dlb), though they are well established in connection with alzheimer's disease (ad). |
2015-01-26 |
2023-08-12 |
Not clear |
| Andrew Siderowf, Michael J Pontecorvo, Holly A Shill, Mark A Mintun, Anupa Arora, Abhinay D Joshi, Ming Lu, Charles H Adler, Douglas Galasko, Carolyn Liebsack, Daniel M Skovronsky, Marwan N Sabbag. PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders. BMC neurology. vol 14. 2015-01-16. PMID:24716655. |
biomarkers based on the underlying pathology of alzheimer's disease (ad) and dementia with lewy bodies (dlb) have the potential to improve diagnosis and understanding of the substrate for cognitive impairment in these disorders. |
2015-01-16 |
2023-08-13 |
Not clear |